📊 Industry Moves
Whoop’s Restore is finally the experiment that matters: >100 post-op patients across three clinics, first outcome data in two weeks, durability proof at one year. If the numbers hold, payers stop treating wearables as fitness gadgets and start covering them as medical devices.
Marty’s Take:
Everyone’s focused on the opioid reduction headline, but the real signal is insurance reimbursement. If Restore produces clean outcome data, payers gain direct financial incentive to cover the Whoop 4.0 as durable medical equipment—flipping the wearable model from consumer subscription to clinical billing. Fitness trackers that don’t pursue a clinical lane will look like lifestyle accessories by comparison within two years.
Shop mentioned gear: Whoop partners
Source: MedTech Dive
Related Reviews
